Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

  • Meiji Holdings: operating profit exceeds plan despite rising raw material costs

    Meiji Holdings reported a consolidated operating profit of ¥40.9 billion for H1 FY2025, 3.7% above its internal plan despite a 7.8% year‑on‑year decline. Net sales edged up to ¥574.8 billion but remained 2.4% below plan, while profit attributable to owners fell to ¥21.4 billion. Meiji carried out price increases and structural reforms, highlighted strong pharmaceutical performance, and confirmed its full‑year operating profit target of ¥91.0 billion, but cut its sales forecast to ¥1,177.0 billion. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2026, Meiji has already paid €0.28 in dividends. The last payout was in June.

Financials

In the last quarter, Meiji had revenue of €1.73B and net profit of €77.17M

(EUR) September 2026
YoY
Revenue 1.73B 0.21%
Gross profit 530.41M 2.88%
Net profit 77.17M 17.76%
EBITDA 228.57M 14.96%

Fundamentals

Metric Value
Market capitalization
€7.2B
Number of shares
271.18M
52-week high/low
€27.24 - €18.09
Dividend yield
2.22%
Dividends TTM
€0.57
Next dividend
€0.32
Beta
0.11
P/E ratio
29.36
PEG ratio
-4.76
P/B ratio
1.60
P/S ratio
1.05

Company profile

Meiji Holdings Co., Ltd., through its subsidiaries, manufactures and sells dairy products, confectioneries, nutritional products, and pharmaceuticals in Japan and internationally. The company operates through two segments, Food and Pharmaceutical. It provides yogurt, drinking milk, beverages, cheese, butter and margarine, cream, ice cream, frozen foods, chocolates, gummy products, chewing gums, candies, sports nutrition products, infant and eternal formula, beauty supplements, OTC drugs, livestock products, and sugar, as well as transportation and distribution services. The company also provides drugs for infectious diseases and central nervous system disorders, as well as generic drugs; agricultural and livestock chemicals; human and veterinary vaccines, and blood plasma products; and veterinary drugs for livestock and fisheries comprising antimicrobial injection, oral administration, antipyretic, analgesic, anti-inflammatory, hemostatic, and breeding agents, disinfectants, insecticides, anthelmintics, metabolites, feed additives, and mixed feed; and companion animals, including anesthetics and painkillers, anti-parasitic and gastrointestinal drugs, anti-bacterial agents, antiplasmin agents, vitamin E preparations, and dietary supplements. Meiji Holdings Co., Ltd. was founded in 1916 and is headquartered in Tokyo, Japan.

Name
Meiji
CEO
Katsunari Matsuda
Headquarters Tokyo, ty
Japan
Website
IPO
01/04/2000
Employees 17,103

Ticker symbols

Exchange Symbol
Japan Exchange Group
2269.T
Pnk
MEJHF
Frankfurt
3M0.F
Düsseldorf
3M0.DU
München
3M0.MU
🍪

Parqet  uses cookies. Learn more